Read + Share
Nassar AH, Adib E, Abou Alaiwi S, El Zarif T, et al. Ancestry-driven recalibration of tumor mutational burden and disparate clinical
outcomes in response to immune checkpoint inhibitors. Cancer Cell 2022;40:1161-1172.
PMID: 36179682
|
 |
|
Nassar AH, Adib E, Abou Alaiwi S, El Zarif T, et al. Ancestry-driven recalibration of tumor mutational burden and disparate clinical
outcomes in response to immune checkpoint inhibitors. Cancer Cell 2022;40:1161-1172.
PMID: 36179682
|
|
|
|